Medical Cannabis in America: The Medical Cannabis Briefing Book is designed for Members of the 116th Congress, lawmakers and regulators everywhere. In addition to policy recommendations, the Briefing Book contains ASA's expansive new legislative solution for a rescheduled or descheduled cannabis future. The Medical Cannabis Control Act of 2019 will create a new federal agency to oversee medical cannabis and remove that authority from NIDA, DOJ, HHS, and FDA. With a focus on patient safety and not criminal prosecutions, this agency will assist state programs to help medical cananbis patients rather than hinder them.
Share this page
